Marthe Vandevelde, Andreas Simoens, Bavo Vandekerckhove and Christian Stevens
{"title":"Synthesis and bioactivity of psilocybin analogues containing a stable carbon–phosphorus bond†","authors":"Marthe Vandevelde, Andreas Simoens, Bavo Vandekerckhove and Christian Stevens","doi":"10.1039/D4MD00043A","DOIUrl":null,"url":null,"abstract":"<p >Psilocybin analogues have been synthesized comprising a non-hydrolysable P–C bond to evaluate the biological activity and the selectivity towards 5-HT<small><sub>2A</sub></small>R, 5-HT<small><sub>2B</sub></small>R and the TNAP receptor. No activity was observed towards the phosphatase, however all compounds showed good binding affinity for 5-HT<small><sub>2A</sub></small>R and 5-HT<small><sub>2B</sub></small>R and one compound showed a higher selectivity towards 5-HT<small><sub>2A</sub></small>R than psilocin.</p>","PeriodicalId":88,"journal":{"name":"MedChemComm","volume":" 3","pages":" 998-1002"},"PeriodicalIF":3.5970,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://pubs.rsc.org/en/content/articlepdf/2024/md/d4md00043a?page=search","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MedChemComm","FirstCategoryId":"1085","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2024/md/d4md00043a","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Psilocybin analogues have been synthesized comprising a non-hydrolysable P–C bond to evaluate the biological activity and the selectivity towards 5-HT2AR, 5-HT2BR and the TNAP receptor. No activity was observed towards the phosphatase, however all compounds showed good binding affinity for 5-HT2AR and 5-HT2BR and one compound showed a higher selectivity towards 5-HT2AR than psilocin.
期刊介绍:
Research and review articles in medicinal chemistry and related drug discovery science; the official journal of the European Federation for Medicinal Chemistry.
In 2020, MedChemComm will change its name to RSC Medicinal Chemistry. Issue 12, 2019 will be the last issue as MedChemComm.